Prevalence and Association of Microalbuminuria in Essential Hypertensive Patients

被引:14
|
作者
Poudel, Bibek
Yadav, Binod Kumar
Nepal, Ashwini Kumar
Jha, Bharat
Raut, Kanak Bahadur
机构
关键词
Albumin creatinine ratio; Hypertension; Normotension; Microalbuminuria;
D O I
10.4103/1947-2714.99501
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Microalbuminuria in hypertension has been described as an early sign of kidney damage and a predictor for end stage renal disease and cardiovascular disease. Thus, it is of great importance to study urinary albumin creatinine ratio and progression of kidney disease in hypertensive patients. Aims: The present study was undertaken to find out the prevalence and association of microalbuminuria in newly diagnosed essential hypertension. Materials and Methods: Newly diagnosed essential hypertensive cases (n = 106) and normotensive controls (n = 106) were enrolled. Hypertension was defined according to Joint national committee-VII definitions. Microalbuminuria was measured using an U-Albumin (NycoCard, Norway) and adjusted for urine creatinine. Descriptive statistics and testing of hypothesis were used for the analysis using SPSS 16 software. Results: 51.88% of hypertension cases and 13.2% of normotensive controls had microalbuminuria in total population (odds ratio 7.086, P-value <0.001). 46.67% of cases and 12.08% of controls had microalbuminuria in male population (odds ratio 6.375, P-value <0.001). Similarly, 58.7% of cases and 14.58% of controls had microalbuminuria in female population (odds ratio 8.32, P-value <0.001). Conclusions: By showing strong association between microalbuminuria and hypertension, our findings suggest that microalbuminuria could be a useful marker to assess risk management of cardiovascular disease and renal disease.
引用
收藏
页码:331 / 335
页数:5
相关论文
共 50 条
  • [31] Correlation between estimated glomerular filtration rate and microalbuminuria in treated essential hypertensive patients
    Campo, C
    Segura, J
    Roldan, C
    Fernandez, L
    Guerrero, L
    Ruilope, LM
    AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 89A - 89A
  • [32] C-reactive protein levels is the major determinant of microalbuminuria in essential hypertensive patients
    Lin, CC
    Tsai, WC
    Huang, YY
    Li, WT
    Lee, CH
    Chen, JY
    Chen, JH
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 336A - 337A
  • [33] PREVALENCE OF MICROALBUMINURIA IN A LARGE POPULATION OF PATIENTS WITH MILD TO MODERATE ESSENTIAL-HYPERTENSION
    BIGAZZI, R
    BIANCHI, S
    CAMPESE, VM
    BALDARI, G
    NEPHRON, 1992, 61 (01): : 94 - 97
  • [34] INCREASED PREVALENCE OF MICROALBUMINURIA IN HYPERTENSIVE ASIAN AMERICAN ADULTS
    Visaria, Aayush
    Sharma, Akarsh
    Islam, Sumaiya
    James, Joel
    Polamarasetti, Pooja
    Raju, Priyanka
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1654 - 1654
  • [35] Prevalence and clinical characteristics of microalbuminuria in the Spanish hypertensive population
    de la Sierra, Alejandro
    Egocheaga, Maria Isabel
    Aguilera, Maria Teresa
    MEDICINA CLINICA, 2008, 130 (06): : 201 - 205
  • [36] Microalbuminuria prevalence study (MAPS) in hypertensive Type 2 diabetic patients in Asia.
    Yoo, SJ
    Pan, C
    Wu, A
    Kong, N
    Yeung, VTF
    de Leon, F
    Tai, T
    Tournerie, C
    Beh, K
    Rouillon, A
    Weir, M
    DIABETOLOGIA, 2003, 46 : A31 - A31
  • [37] PREVALENCE OF MICROALBUMINURIA (MAU) IN HYPERTENSIVE, NONDIABETIC PATIENTS WITH/WITHOUT END-ORGAN DAMAGE
    AGRAWAL, B
    WOLF, K
    BERGER, A
    KIDNEY INTERNATIONAL, 1995, 47 (03) : 962 - 962
  • [38] Prevalence and associated factors of microalbuminuria in non-diabetic hypertensive patients in the community of Koper
    Fabris, H.
    Stemberger, A.
    Kersnik, J.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 156S - 156S
  • [39] Association between hyperlipidemia and microalbuminuria in essential hypertension
    Campese, VM
    Bianchi, S
    Bigazzi, R
    KIDNEY INTERNATIONAL, 1999, 56 : S10 - S13
  • [40] A microalbuminuria prevalence study (MAPS) in hypertensive type 2 diabetic patients in Asia.
    Weir, M
    Wu, A
    de Leon, F
    Kong, N
    Pan, C
    Tai, TY
    Yeung, VT
    Yoo, SJ
    Rouillon, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 680A - 680A